Pyrrole tricyclic compounds as A2A / A2B inhibitors

This application relates to compounds of Formula (I):or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors i...

Full description

Saved in:
Bibliographic Details
Main Authors He, Chunhong, Huang, Taisheng, Carlsen, Peter Niels, Wang, Xiaozhao
Format Patent
LanguageEnglish
Published 11.01.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:This application relates to compounds of Formula (I):or pharmaceutically acceptable salts or stereoisomers thereof, which modulate the activity of adenosine receptors, such as subtypes A2A and A2B receptors, and are useful in the treatment of diseases related to the activity of adenosine receptors including, for example, cancer, inflammatory diseases, cardiovascular diseases, and neurodegenerative diseases.
Bibliography:Application Number: US201916377793